FDA has altered a planned survey of how prescribers view direct-to-consumer (DTC) advertising by cutting several questions while attempting to glean more detailed information on the prescriber-patient relationship and prescribers’ demographics and feelings.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?